Manulife (Manufacturers Life Insurance)
MRNA icon

Manulife (Manufacturers Life Insurance)’s Moderna MRNA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Sell
314,872
-132,808
-30% -$6.2M 0.01% 675
2025
Q4 		$13.2M Sell
447,680
-8,265
-2% -$225K 0.01% 759
2025
Q3 		$11.8M Buy
455,945
+64,991
+17% +$1.81M 0.01% 786
2025
Q2 		$10.8M Buy
390,954
+688
+0.2% +$18.1K 0.01% 806
2025
Q1 		$11.1M Sell
390,266
-2,951,658
-88% -$105M 0.01% 787
2024
Q4 		$139M Buy
3,341,924
+267,990
+9% +$12.8M 0.12% 167
2024
Q3 		$205M Buy
3,073,934
+178,939
+6% +$16.4M 0.18% 124
2024
Q2 		$344M Sell
2,894,995
-583,417
-17% -$73.8M 0.32% 67
2024
Q1 		$371M Sell
3,478,412
-64,555
-2% -$6.51M 0.34% 64
2023
Q4 		$352M Sell
3,542,967
-333,180
-9% -$28M 0.21% 81
2023
Q3 		$400M Buy
3,876,147
+1,690,341
+77% +$189M 0.23% 77
2023
Q2 		$266M Buy
2,185,806
+53,833
+3% +$7.18M 0.15% 115
2023
Q1 		$327M Sell
2,131,973
-90,355
-4% -$14.9M 0.18% 96
2022
Q4 		$399M Sell
2,222,328
-83,140
-4% -$13.6M 0.25% 68
2022
Q3 		$273M Sell
2,305,468
-40,807
-2% -$6.19M 0.19% 91
2022
Q2 		$335M Sell
2,346,275
-12,191
-0.5% -$1.74M 0.23% 76
2022
Q1 		$406M Buy
2,358,466
+177,647
+8% +$29.9M 0.27% 76
2021
Q4 		$553K Buy
2,180,819
+943,271
+76% +$276M 0.34% 58
2021
Q3 		$476M Sell
1,237,548
-104,570
-8% -$38.6M 0.39% 60
2021
Q2 		$315M Buy
1,342,118
+523,735
+64% +$93.6M 0.26% 88
2021
Q1 		$107M Buy
818,383
+510,602
+166% +$74M 0.09% 219
2020
Q4 		$32.2M Sell
307,781
-394,395
-56% -$39.9M 0.03% 455
2020
Q3 		$49.7M Sell
702,176
-41,925
-6% -$2.92M 0.05% 323
2020
Q2 		$46.2M Sell
744,101
-437,515
-37% -$24M 0.04% 328
2020
Q1 		$35.4M Buy
1,181,616
+14,719
+1% +$339K 0.04% 344
2019
Q4 		$22.8M Sell
1,166,897
-45,986
-4% -$816K 0.02% 516
2019
Q3 		$19.3M Sell
1,212,883
-25,120
-2% -$371K 0.02% 561
2019
Q2 		$18.1M Buy
1,238,003
+747,148
+152% +$16M 0.02% 591
2019
Q1 		$9.99M Buy
490,855
+93,158
+23% +$1.73M 0.01% 862
2018
Q4 		$6.07M Buy
+397,697
New +$6.54M 0.01% 1054

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s MRNA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Moderna (MRNA) stake by 30% in Q1 2026, selling an estimated $6.2M and leaving 314,872 shares worth $16M. The position accounts for 0.01% of the portfolio, ranked #675.

Manulife (Manufacturers Life Insurance) first reported a position in MRNA in Q4 2018 and has held it in 30 quarters since. The position peaked at $476M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 314,872 shares of Moderna worth $16M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 132,808 Moderna shares in Q1 2026, an estimated $6.2M.
  • Moderna made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #675 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Moderna in Q4 2018 and has held it in 30 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Moderna position peaked at $476M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.